1. Reliability and validity of a newly developed PANDAS/PANS questionnaire.
- Author
-
Bleibach, Akita, Sørensen, Camilla Birgitte, Skov, Liselotte, Christensen, Karl Bang, and Debes, Nanette Mol
- Subjects
ATTENTION-deficit hyperactivity disorder ,STREPTOCOCCAL diseases ,NEUROBEHAVIORAL disorders ,AUTOIMMUNE diseases ,PANDAS - Abstract
This study aimed to examine the reliability and validity of a newly developed questionnaire for Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal infections (PANDAS) and Pediatric Acute-onset Neuropsychiatric Syndrome (PANS). The aim was to contribute to future standardisation of screening methods for symptoms and comorbidity, as well as the measurement of symptom severity, daily life impairment, and treatment effectiveness in individuals diagnosed with PANDAS/PANS. 27 items from the PANDAS/PANS questionnaire concerning symptoms and comorbidities associated with PANDAS/PANS were divided into ten domains. To assess the external validity, 119 PANDAS/PANS questionnaires from a cohort of 65 children with PANDAS/PANS were correlated with three well-known validated questionnaires: the Children's Yale-Brown Obsessive-Compulsive Scale (CY-BOCS), Attention Deficit Hyperactivity Disorder Rating Scale (ADHD-RS), and the Strengths and Difficulties Questionnaire (SDQ). The internal validity of the PANDAS/PANS questionnaire was assessed by correlating the PANDAS/PANS items with the domains. Internal consistency of the PANDAS/PANS questionnaire was high, measuring moderate to very strong correlations. The external correlations for the PANDAS/PANS questionnaire showed a higher correlation with the ADHD-RS and CY-BOCS (r s ≥ 0.60) than with the SDQ (r s < 0.40). The validity and clinical feasibility of the PANDAS/PANS questionnaire were confirmed as an effective tool for screening symptoms, assessing symptom severity, and evaluating comorbidity and daily life impairment in individuals with PANDAS/PANS. These findings can potentially enhance the management of PANDAS/PANS patients in both clinical and research settings. • A new PANDAS/PANS questionnaire is an effective tool for screening symptoms. • Correlated with validated questionnaires with strong external correlations. • High internal consistency across ten PANDAS/PANS domains. • Potentially enhances the management of PANDAS/PANS patients. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF